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1076Syncope Without Prodromes in Patients With Normal Heart and
Normal ElectrocardiogramA Distinct EntityObjectives This study sought to investigate the clinical and laboratory ﬁndings of patients affected by sudden-onset syncope
without prodromes who had a normal heart and normal electrocardiogram.Background The pathophysiology of syncope in these patients is uncertain.Methods We compared the clinical and laboratory ﬁndings of 15 patients with sudden-onset syncope without prodromes who
had a normal heart and normal electrocardiogram (the study group) with those of 31 patients with established
vasovagal syncope (VVS).Results The patients in the study group were older than those with VVS (age 61  12 years vs. 46  17 years) and had
a history of fewer episodes of syncope (median of 2 [interquartile range [IQR]: 1 to 2.5] vs. 9 [IQR: 4 to 15] years)
that were of more recent onset (median of 1 [IQR: 0 to 1] vs. 10.5 [IQR: 3.3 to 27] years). The study group had lower
median baseline adenosine plasmatic levels than the VVS group (0.25 mmol/l [95% conﬁdence interval: 0.10 to 1.51]
vs. 0.85 mmol/l [95% conﬁdence interval: 0.32 to 2.80]). On receiver-operating characteristic curve analysis, the
adenosine plasmatic level of 0.36 best discriminated between groups, displaying 73% sensitivity and 93%
speciﬁcity. Tilt table testing was more frequently positive in patients with VVS than in the study group (74% vs. 33%). A
similarly high positivity rate of adenosine/adenosine triphosphate testing was found in both groups.Conclusions Common clinical features and a low adenosine plasmatic level deﬁne a distinct form of syncope, distinguish it
from VVS, and suggest a causal role of the adenosine pathway. (J Am Coll Cardiol 2013;62:1075–80) ª 2013
by the American College of Cardiology FoundationIn patients without structural heart disease and a normal
electrocardiogram (ECG), once nonsyncopal causes of loss
of consciousness are excluded, syncope is usually regarded as
a manifestation of an abnormal vasovagal reﬂex (1). Vaso-
vagal syncope (VVS) is typically preceded by prodromes due
to autonomic activation and triggered by predisposing
factors. Virtually all episodes of VVS induced during tilt
table testing are preceded by prodromes, which start 30 to
60 s before the loss of consciousness (2,3). In rare cases,
the absence of prodromes during spontaneous episodes of
VVS is attributed to retrograde amnesia (1,4). Conversely,
syncope occurring without prodromes in patients with
structural heart disease is regarded as an ominous ﬁnding
suggestive of a cardiac arrhythmia as the cause of syncope
(Stokes-Adams attack) (1,5,6). In the absence of structural
heart disease and conduction abnormalities on ECG, cardiac
syncope is very unlikely and the results of an electrophysi-
ological study are invariably negative (7,8). Therefore, in
patients affected by syncope without prodromes who have
a normal heart and normal ECG, the diagnosis of syncope
remains unexplained (1).
In this study, we described the peculiar clinical charac-
teristics of patients with this form of unexplained syncope
and assessed the potential causal role of plasmatic adenosine.
Methods
The study group included 15 consecutive patients with sudden-
onset syncope without prodromes who had a normal heartand normal electrocardiogram. The absence of prodromes was
carefully investigated, and doubtful cases were excluded.
Speciﬁcally, we excluded patients if retrograde amnesia could
not be ruled out, especially in the context of unexplained
falls in older adults. An eyewitness account was often the
vital key in establishing whether a deﬁnite syncope had
occurred.
The control group included 31 consecutive patients with
typical VVS (1), characterized by the presence of well-
identiﬁable triggers (central [i.e., emotional distress] or
peripheral [i.e., prolonged standing]) and preceded by
symptoms of autonomic activation (i.e., feeling of warmth, an
odd sensation in the abdomen, and lightheadedness or
dizziness, nausea, and sweating). Atypical forms of VVS (e.g.
those with short prodromes or without identiﬁable triggers)
were excluded.
Once enrolled, patients in the study group and control
group underwent a common protocol, which included assay of
the baseline adenosine plasmatic level (APL), tilt table testing,
and an adenosine or adenosine triphosphate (ATP) test. No
patient dropped out of the study or was excluded at this stage.
The APL was determined as previously described (9).
Baseline blood samples were collected (with the patients in
a supine position) and processed using laboratory-prepared
tubes containing 3 ml of cold-stop solution under vacuum.
This method allows whole blood to mix quickly with the
cold-stop solution, thus preventing degradation or adeno-
sine uptake by red blood cells. After collection, samples
were immediately placed and maintained on ice until
Abbreviations
and Acronyms
APL = adenosine plasmatic
level
ATP = adenosine
triphosphate
AV = atrioventricular
ECG = electrocardiogram
VVS = vasovagal syncope
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1077centrifugation. After deproteinization, adenosine was qua-
ntiﬁed using high-pressure liquid chromatography (Chro-
mSystems, Munchen, Germany). The technicians who
treated the samples and performed the assays were unaware
of the patient’s study group assignment. All APL assays
were performed in the Laboratory of Biochemistry and
Molecular Biology of Timone University Hospital (Mar-
seille, France). The normal median laboratory APL,
measured in 81 control subjects without syncope (mean age,
59  12 years; 43 male subjects), is 0.49 mmol/l (inter-
quartile range: 0.38 to 0.68 mmol/l).
Adenosine and ATP tests were performed by means of
rapid injection (<2 s) of 20 mg of ATP or 18 mg of
adenosine via a brachial vein, followed by a 10 ml 5% glucose
ﬂush. Positivity was deﬁned as complete atrioventricular
(AV) block with ventricular asystole >6 s (10) or third-
degree AV block >10 s (11).
Tilt table testing, both passive and potentiated with nitro-
glycerin, was performed according to the Italian protocol (12).
Statistical analysis. Continuous data are shown as averages
 SD or medians (25th to 75th percentile) as appropriate.
The Shapiro-Wilks test was performed to check the skewness
of distributions. Absolute and relative frequencies were used
to show categorical data. The unpaired Student t test and
the nonparametric Mann-Whitney U test were used to
compare continuous variables as appropriate. Fisher exact
test was used to compare proportions. The ability of the
APL to distinguish patients in the study group from patients
with VVS was evaluated using receiver-operating char-
acteristic curve analysis. MedCalc Software (Mariakerke,
Belgium) was used for statistical analysis.Results
Patient characteristics and test results of the 15 patients in
the study group and 31 patients with VVS are shown in
Table 1. The patients in the study group were older than
those with VVS and had a history of fewer episodes of
syncope that were of more recent onset. In all patients in the
study group, syncope was unpredictable and displayed no
detectable trigger. The study group had a lower median
baseline APL than the VVS group (Table 2). On receiver-
operating characteristic curve analysis, the APL of 0.36
showed the highest accuracy (minimal false-negative and
false-positive results), displaying 73% sensitivity and 93%
speciﬁcity (Table 3). A similarly high positivity rate on
adenosine/ATP testing was found in both groups. The tilt
table testing was more frequently positive in patients with
VVS than in the study group.
Discussion
Patients with unexplained sudden-onset syncope without
prodromes who have a normal heart and normal electrocar-
diogram are typically>40 years of age and have a recent onset
of history of syncope in middle/old age and low APL. Thelate onset of the syndrome sug-
gests a pathological process or,
more generally, an aging process.
The clinical features described in
the preceding text clearly distin-
guish these patients from those
with VVS; syncope in patients
with VVS should be regarded as
an isolated manifestation of in-
dividual differences in the sus-
ceptibility of the autonomic nervous
system that are probably present in
all healthy subjects (13).
The lack of evidence of activation of a central or
peripheral baroreﬂex (no signs or symptoms of autonomic
activation or triggers) and the peculiar APL proﬁle
prompted us to hypothesize a pivotal role of biochemical or
neurohumoral mechanisms. Patients with sudden-onset
syncope without prodromes who have a normal heart and
normal electrocardiogram are “low adenosine syncope”
patients, as opposed to patients with VVS, who are “high
adenosine” patients (14,15). Indeed, in the present study,
“low adenosine syncope” patients had APLs that were lower
not only than those of patients with VVS but also those of
healthy subjects without syncope (p ¼ 0.01 compared with
81 control subjects from the core laboratory; see Methods).
Only 7% of patients with VVS and 21% of healthy subjects
had an APL less than the cutoff of 0.36 mmol/l (Fig. 1). The
difference in APLs between the study group and the VVS
group was unrelated to an effect of different ages (Fig. 2);
the control subjects and patients in the study group were of
similar age. Involvement of the adenosine pathway is also
suggested by the observed 60% rate of positive responses to
adenosine/ATP testing, deﬁned as an AV block with
a pause 6 s, which was higher than the 28% rate observed
in a general syncope population and the 5% rate observed in
subjects without syncope (10). Because the results of aden-
osine/ATP testing were also frequently positive in patients
with VVS, this tool was unable to distinguish between the 2
groups, unlike APL. Admittedly, although a role of the
adenosine pathway in the genesis of syncope is possible,
these data are insufﬁcient to prove a causal relationship,
because a low APL is only a marker or an associated
condition of a more complex mechanism. Syncope due to
extrinsic (or functional) mechanisms in patients with
a normal heart probably involves a wide spectrum of path-
ogenic pathways in addition to adenosine. Several other
alterations in neurohumoral mechanisms have been advo-
cated: epinephrine, serotonin, tyrosine hydroxylase and
norepinephrine transporter proteins, and so on (16,17).
Finally, the observed different positivity rate of the tilt table
test also supports a different mechanism in the 2 groups; the
positivity rates observed in this study are consistent with the
ﬁndings of another study that showed greater positivity in
patients with clinical triggers (71% central and 75% periph-
eral) than in those without (36%) (18).
Table 1 Patient Characteristics and Test Results of the 15 Patients in the Study Group and the 31 Patients With Vasovagal Syncope
Patient
# Age/Sex
Total No.
With
Syncope
No. of
Syncopes
in the
Past 2 Yrs
Duration of
Syncope (yrs)
Adenosine
Plasmatic
Level
(mmol/l)
ATP Test:
Pause >6 s
(Duration [s])
ATP Test: Duration
of Third-Degree
Atrioventricular
Block >10 s
(Duration [s])
Tilt Table
Testing
Patients in the study group
1 68/F 1 1 0 0.13 No No Negative
2 44/M 1 0 0 0.36 Yes (10.6) Yes (16) Negative
3 69/F 12 4 9 0.25 No Yes (13.2) Positive (mixed)
4 68/F 1 1 1 0.10 No No Negative
5 56/M 1 1 1 0.31 Yes (6.9) Yes (12) Negative
6 46/F 3 3 1 0.25 No No Negative
7 41/M 5 5 1 0.10 Yes (6.3) Yes (12.1) Negative
8 64/F 2 2 0 1.20 No No Positive (mixed)
9 47/F 2 2 1 0.11 Yes (8.2) No Negative
10 62/M 2 2 1 0.50 Yes (7) No Positive (mixed)
11 63/F 1 1 0 0.18 Yes (6.2) No Negative
12 75/M 2 2 0 0.11 Yes (9) No Negative
13 55/F 3 1 12 0.12 Yes (6.4) No Positive (mixed)
14 68/F 1 1 0 2.00 Yes (10.4) Yes (10.4) Positive (mixed)
15 85/F 1 1 0 1.30 No No Negative
Patients with vasovagal syncope
1 60/F 50 20 40 0.7 Yes (7.2) Yes (25) Positive (CI)
2 44/F 10 4 30 NA No Yes (12.9) Positive (mixed)
3 17/F 10 6 5 0.26 No No Positive (CI)
4 31/M 3 2 15 1.67 No No Positive (CI)
5 37/F 3 2 3 0.9 No No Positive (mixed)
6 39/M 10 6 7 0.25 No No Positive (CI)
7 76/F 2 1 29 0.56 Yes (6.1) No Negative
8 50/F 1 0 0 0.8 No Yes (22) Negative
9 30/M 10 3 20 1.69 No Yes (16.8) Positive (CI)
10 32/M 4 1 16 1.8 No No Negative
11 42/F 15 3 32 0.5 Yes (11.5) Yes (18) Positive (CI)
12 37/F 100 NA NA 3.2 NA NA Negative
13 24/F 20 4 16 1.7 No No Positive (mixed)
14 40/F 4 1 20 2.3 Yes (6.2) No Positive (mixed)
15 49/F 10 1 30 1.8 No No Positive (mixed)
16 21/F 15 6 11 0.45 Yes (6.4) Yes (24) Positive (mixed)
17 23/M 50 10 10 0.4 Yes (6.1) No Positive (mixed)
18 37/F 6 4 3 0.51 Yes (8.4) Yes (21.6) Positive (CI)
19 19/F 3 3 1 1.2 Yes (40) Yes (30) Positive (mixed)
20 42/F 30 15 10 0.7 Yes (14.2) Yes (18.4) Negative
21 62/M 5 5 0 0.7 No No Positive (CI)
22 55/M 5 2 20 0.69 No No Positive (mixed)
23 56/M 2 2 0 1.2 No No Positive (mixed)
24 67/F 4 2 5 0.8 Yes (9.4) No Positive (mixed)
25 62/F 15 1 45 0.7 Yes (11.2) Yes (11.2) Positive (CI)
26 49/M 2 2 0 1.5 No No Positive (mixed)
27 39/M 4 4 0 0.4 No No Negative
28 72/F 17 2 60 3.2 Yes (9.8) No Negative
29 71/M 6 2 10 0.9 No No Positive (mixed)
30 61/F 10 1 35 1.7 No No Positive (mixed)
31 79/M 9 4 4 0.96 Yes (12) Yes (12) Negative
ATP ¼ adenosine triphosphate; CI ¼ cardioinhibitory (pause >3 s); NA ¼ not available.
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1078The laboratory features of “low adenosine syncope”
patients were fairly similar to those we previously observed
in patients with idiopathic AV block (19). These latterpatients had a median APL of 0.33 (interquartile range:
0.20 to 0.36) (Fig. 1); the adenosine/ATP test result was
positive (i.e., pause >6 s) in 67%, and the tilt table test
Table 2 Comparison Between Study Group and Patients With VVS
No Prodromes, Normal
Heart, and Normal
Electrocardiogram Typical VVS p Value
n 15 31
Age (yrs) 61  12 46  17 0.005
Female 10 (71%) 19 (61%) 1.0
Total no. of syncopes 2 (1–2.5) 9 (4–15) 0.0001
No. of syncopes in the past 2 yrs 1 (1–2) 2.5 (2–4) 0.03
Duration of syncope (yrs) 1 (0–1) 10.5 (3.3–27) 0.0005
APL (mmol/l), median (95% conﬁdence interval) 0.25 (0.10–1.51) 0.85 (0.32–2.80) 0.0004
APL 0.36 mmol/l (receiving-operating
characteristic curve discriminant)
11 (73%) 2/30 (7%) 0.0001
Adenosine/ATP test, pause >6 s 9 (60%) 13/30 (43%) 0.35
Adenosine/ATP test, third-degree atrioventricular
block >10 s
5 (33%) 11/30 (37%) 1.0
Positive tilt table test result 5 (33%) 23 (74%) 0.01
Values are n, mean  SD, n (%), or median (interquartile range). The APL was not available for 1 patient with VVS because of technical
problems, and the ATP test was not performed in 1 patient with VVS because of patient refusal.
APL ¼ adenosine plasmatic level; ATP ¼ adenosine triphosphate; IQR ¼ interquartile range; VVS ¼ vasovagal syncope.
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1079result was positive in 41%. Moreover, most patients with
idiopathic AV block also had sudden-onset syncope
without prodromes or triggers, absence of structural heart
disease, and a normal ECG. Patients with idiopathic AV
block also had ECG documentation of a paroxysmal AV
block with a long pause that was responsible for syncope.
We therefore hypothesized that, in idiopathic paroxysmal
AV block, the effect of adenosine on the AV node is
mainly due to the stimulation of high-afﬁnity A1 receptors,
which are much more numerous in the AV node than in
the sinoatrial node (20–22). Like many other cell surface
receptors, the number of cardiac adenosine A1 receptors
undergoes up-regulation and down-regulation when cardiac
tissues are chronically exposed to low or elevated concen-
trations of adenosine receptor agonist (i.e., adenosine),
respectively. A transient release of endogenous adenosine
could be sufﬁcient to block conduction in the AV node
when a large number of free high-afﬁnity A1 receptors inTable 3 Criterion Values and Coordinates of the Receiver-Operating
Criterion Sensitivity 95% CI Spe
<0.1 0.00 0.0–22.0 10
0.18 46.67 21.3–73.4 10
0.25 60.00 32.3–83.6 9
0.26 60.00 32.3–83.6 9
0.36* 73.33 44.9–92.0 9
0.45 73.33 44.9–92.0 8
0.5 80.00 51.9–95.4 8
0.96 80.00 51.9–95.4 4
1.2 86.67 59.5–98.0 3
1.3 93.33 68.0–98.9 3
1.8 93.33 68.0–98.9 1
2 100.00 78.0–100.0 1
3.2 100.00 78.0–100.0
*The value corresponding to the highest accuracy (minimal false-negative and false-positive results).
CI ¼ conﬁdence interval; þLR ¼ positive likelihood ratio; LR ¼ negative likelihood ratio.the AV node are available (patients with low APLs) but not
when long-term exposure to high APLs desensitizes A1
receptors (patients with VVS who have high APLs)
(14,19). The clinical characteristics and results of laboratory
tests of the patients in the present study are in favor of
a large overlap between these patients and patients with
idiopathic AV block. If this is conﬁrmed, the identiﬁcation
of patients with idiopathic AV block would become much
easier, without need for ECG documentation of the
syncope. A prospective study aimed at documenting spon-
taneous syncope in patients with sudden onset of low APL
by means of an implantable loop recorder is ongoing.
Conclusions
Common clinical features and a low APL deﬁne a distinct
form of syncope, distinguish it from VVS, and suggest
a causal role of the adenosine pathway. “Low adenosineCharacteristic Curve
ciﬁcity 95% CI þLR LR
0.00 88.3–100.0 1.00
0.00 88.3–100.0 0.53
6.67 82.7–99.4 18.00 0.41
3.33 77.9–99.0 9.00 0.43
3.33 77.9–99.0 11.00 0.29
3.33 65.3–94.3 4.40 0.32
0.00 61.4–92.2 4.00 0.25
0.00 22.7–59.4 1.33 0.50
3.33 17.3–52.8 1.30 0.40
3.33 17.3–52.8 1.40 0.20
0.00 2.2–26.6 1.04 0.67
0.00 2.2–26.6 1.11 0.00
0.00 0.0–11.7 1.00
Figure 1
Individual APLs in 15 “Low Adenosine Syncope”
Patients, 30 Patients With VVS, 18 Patients With
Idiopathic Paroxysmal Atrioventricular Block, and
81 Control Subjects Without Syncope
The individual adenosine plasmatic levels (APLs) of the 4 groups of patients
are plotted. The median APL of each group is also shown. The data regarding
Idiopathic AV block and no syncope are reprinted from Brignole et al. (19).
AVB ¼ atrioventricular block; VVS ¼ vasovagal syncope.
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1080syncope” is characterized by age >40 years, recent onset in
middle/old age, sudden onset without prodromes, and
a normal heart and normal electrocardiogram.
Reprint requests and correspondence: Dr. Michele Brignole,
Arrhythmologic Center, Department of Cardiology, Ospedali del
Tigullio, Via Don Bobbio 25, 16033 Lavagna, Italy. E-mail:
mbrignole@asl4.liguria.it.Figure 2
Lack of Correlation Between APLs and Age in “Low
Adenosine Syncope” Patients and Patients With VVS
The linear regression line is superimposed. Abbreviations as in Figure 1.REFERENCES
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